Loading…
MiMedx Group will acquire all outstanding shares of Sanara MedTech in a transaction valued at $350 million, combining MiMedx's surgical portfolio with Sanara's technologies in collagen particulate, wound irrigation, and bone fixation.
Sanara MedTech Inc. entered into a definitive merger agreement to acquire Precision Healing Inc. The purchase price consists of approximately $5.1 million in stock and cash, plus earnout obligations, valuing Precision Healing's equity at about $7.8 million.